Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000023EBVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30001593HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30001594HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30011288HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30019016HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30024696HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30024697HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS44015520HTLV-1ENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TCGA Plot Options
Drug Information
GeneKCNA3
DrugBank IDDB06637
Drug NameDalfampridine
Target IDBE0004716
UniProt IDP22001
Regulation Typeantagonist
PubMed IDs16472864
CitationsJudge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9.
GroupsApproved
Direct ClassificationAminopyridines and derivatives
SMILESNC1=CC=NC=C1
Pathways
PharmGKBPA166123389
ChEMBLCHEMBL284348